Zhang Guo-Xin, Jin Ling, Jin Hua, Zheng Gui-Sen
Basic Medical College, Gansu University of Chinese Medicine, Lanzhou 730000, China.
College of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, China.
Evid Based Complement Alternat Med. 2021 Apr 20;2021:5563073. doi: 10.1155/2021/5563073. eCollection 2021.
Hypertension (HTN) is an important worldwide public health issue affecting human health. The pathogenesis of HTN involves complex factors such as genetics, external environment, diet, and the gut microbial dysbiosis. The gut microbiota, as a medium of diet and drug metabolism, is closely correlated to host's health and disease (including HTN). Literatures were randomly collected from various databases including PubMed, ScienceDirect, Google Scholar, and China National Knowledge Infrastructure (CNKI). In this review, we elucidate the relationship between HTN and gut microbiota, as well as concerning the effects of different dietary components, diet-derived microbial metabolites, and traditional Chinese medicine (TCM) on intestinal flora. These studies have shown that diet and TCM can regulate and balance the intestinal flora, which are inclined to increasing the abundance of , , and and reducing the ratio of and . Moreover, monitoring the dynamic change of gut microflora may indicate patient prognosis and personalized response to treatment. This review aims to provide novel perspectives and potential personalized interventions for future HTN management from the perspective of gut microbiota.
高血压(HTN)是一个影响人类健康的重要全球性公共卫生问题。高血压的发病机制涉及遗传、外部环境、饮食和肠道微生物群失调等复杂因素。肠道微生物群作为饮食和药物代谢的媒介,与宿主的健康和疾病(包括高血压)密切相关。从包括PubMed、ScienceDirect、谷歌学术和中国知网(CNKI)在内的各种数据库中随机收集文献。在本综述中,我们阐明了高血压与肠道微生物群之间的关系,以及不同饮食成分、饮食衍生的微生物代谢产物和中药对肠道菌群的影响。这些研究表明,饮食和中药可以调节和平衡肠道菌群,倾向于增加 、 和 的丰度,降低 和 的比例。此外,监测肠道微生物群的动态变化可能预示患者的预后和对治疗的个性化反应。本综述旨在从肠道微生物群的角度为未来高血压管理提供新的视角和潜在的个性化干预措施。